About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
SOHO 2022 Tenth Annual Meeting
Myeloma
Lymphoma
Leukemia
MDS and MPN
Benign Hematology
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
T
The Role of Targeted Therapies in Frontline Treatment of MCL
By
Tycel Phillips
13 Videos
120 views
October 14, 2022
https://www.sohoonline.org/
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Lymphoma
10:00
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Biology and Treatment of LGL Leukemia
Feat.
T. Loughran
10:35
SOHO 2022 Tenth Annual Meeting
SOHO 2022 Next Questions: Hodgkin Lymphoma
Feat.
N. Bartlett
10:19
SOHO 2022 Tenth Annual Meeting
Next Questions: Mantle Cell Lymphoma
Feat.
K. Maddocks
11:27
SOHO 2022 Tenth Annual Meeting
SOHO 2022 Next Questions: T-Cell Lymphoma
Feat.
S. Iyer
12:37
SOHO 2022 Tenth Annual Meeting
SOHO 2022 Next Questions: Follicular Lymphoma
Feat.
G. Salles
15:31
SOHO 2022 Tenth Annual Meeting
SOHO 2022: What's Next in Aggressive B-Cell Lymphoma?
Feat.
L. Sehn
10:34
SOHO 2022 Tenth Annual Meeting
SOHO 2022 Next Questions: Cellular Therapy
Feat.
K. Komanduri
16:19
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro AUTO H…
Feat.
C. Sauter
12:05
SOHO 2022 Tenth Annual Meeting
SOHO 2022 DEBATE: CAR T-Cell vs. AUTO HCT for R/R DLBCL - Pro CAR T-…
Feat.
M. Kamdar
08:34
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Camidanlumab Tesirine - Updated Efficacy and Safety in Pa…
Feat.
A. Herrera
16:42
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Treating Hodgkin Lymphoma After Brentuximab Vedotin and A…
Feat.
A. Herrera
16:18
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Sequencing Novel Agents in Frontline and Second-Line Trea…
Feat.
A. Moskowitz
07:04
SOHO 2022 Tenth Annual Meeting
Phase 1/2 BRUIN Study - Updated Results on Pirtobrutinib in Previous…
Feat.
J. Cohen
19:47
SOHO 2022 Tenth Annual Meeting
Emerging Treatment Options for MCL
Feat.
J. Ruan
13:18
SOHO 2022 Tenth Annual Meeting
Immunotherapeutic Options for Patients With MCL Who Progress on BTK …
Feat.
J. Cohen
14:31
Tycel Phillips
The Role of Targeted Therapies in Frontline Treatment of MCL
16:52
SOHO 2022 Tenth Annual Meeting
Is it Time to Recognize the Biological Heterogeneity of MCL?
Feat.
A. Goy
08:47
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Cost-Effectiveness of Polatuzumab Vedotin in Previously U…
Feat.
J. Burke
08:56
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Results from POLARIX, a Phase III Study of Pola-R-CHP vs.…
Feat.
C. Flowers
13:55
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Managing the Elderly Patient With Aggressive B-cell Lymph…
Feat.
C. Thieblemont
11:32
SOHO 2022 Tenth Annual Meeting
SOHO 2022: CNS Prophylaxis in DLBCL
Feat.
V. Orellana-Noia
14:57
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Treatment of Aggressive B-cell Lymphoma Post-CAR T-Cell T…
Feat.
G. Nowakowski
15:19
SOHO 2022 Tenth Annual Meeting
SOHO 2022: The Emerging Potential of Bispecific Antibodies as Monoth…
Feat.
M. Dickinson
15:03
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Choosing CAR T-Cell Therapy vs. ASCT in R/R Aggressive B-…
Feat.
M. Kamdar
15:33
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Has R-CHOP Really Been Replaced as Initial Therapy of DLB…
Feat.
J. Friedberg
05:56
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Pivotal Results From a Phase I/II Study of Mosunetuzumab …
Feat.
L. Nastoupil
19:37
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Using Biology to Determine Type and Duration of Treatment…
Feat.
P. Kapoor
15:04
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Future Role of Bispecific Antibodies in the Treatment of …
Feat.
E. Budde
15:37
SOHO 2022 Tenth Annual Meeting
SOHO 2022: What Is the Role of Transplantation for FL in the Era of …
Feat.
M. Hamadani
15:08
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Sequencing Therapy in Indolent Lymphoma - Treatment Choic…
Feat.
L. Nastoupil
10:04
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Correlation of TRBC1 by Flow Cytometry With Molecular T-C…
Feat.
T. Dexter
14:13
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Advances in the Treatment of NK/T Cell Lymphoma
Feat.
W. Kim
16:35
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Integrating Novel Agents Into the Management of Cutaneous…
Feat.
P. Allen
15:40
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Novel Treatment Approaches in Relapsed/Refractory PTCL
Feat.
M. Lunning
15:49
SOHO 2022 Tenth Annual Meeting
SOHO 2022: The Next Rational Therapeutic Regimen in Newly Diagnosed …
Feat.
N. Mehta-Shah
14:21
SOHO 2022 Tenth Annual Meeting
SOHO 2022: From Bench to Bedside - A Translational Scientist's …
Feat.
F. Vega
21:46
SOHO 2022 Tenth Annual Meeting
SOHO 2022: CAR T-Cells in Indolent B-Cell Lymphomas
Feat.
J. Abramson
18:24
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Challenging Cases in Rare T-Cell Lymphomas
Feat.
S. Barta
11:16
SOHO 2022 Tenth Annual Meeting
SOHO 2022: Basis for Targeting the Microenvironment in Hodgkin Lymph…
Feat.
C. Steidl
11:27
SOHO 2022 Tenth Annual Meeting
SOHO 2022: CAR T-Cell Therapy in Hodgkin Lymphoma
Feat.
C. Ramos
13:22
SOHO 2022 Tenth Annual Meeting
SOHO 2022: The Next Generation of Novel Agents in Development for Ag…
Feat.
J. Westin
